{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:MMP",
      "entity_text" : "MMPs",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:56927919",
      "entity_text" : "exenatide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In vitro studies have shown that exenatide, a specific glucagon like peptide agonist, prevents degradation of type II collagen and aggrecan in articular cartilage by inhibiting MMPs and ADAMTS.",
  "reading_complete" : "2020-08-03T11:17:58Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:56:47Z",
  "trigger" : "prevents",
  "evidence" : [ "exenatide, a specific glucagon-like peptide agonist, prevents degradation of type II collagen and aggrecan in articular cartilage by inhibiting MMPs" ],
  "pmc_id" : "7261331",
  "score" : 0
}